2Windebank AJ. Chemotherapeutic neuropathy[J]. Curr Opin Neurobiol, 1999, 12(5): 565-571.
3Grisold A. Chemotherapy-induced neuropathy[J]. J Periph- er Nerv Syst, 2008, 1(13): 27-46.
4Rowinsky EK, Onetto N, Canetta RM, et al. Taxol: the first of the taxanes, an important new class of antitumor agents [J]. Semin Oncol, 1992, 19(6): 646-662.
5Nabholtz JM, Gelmon K, Bontenbal M, et al. Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer[J]. J Clin Oncol, 1996, 14(6): 1858-1867.
6Gradishar W J, Davidson N. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated cas- tor oil-based paclitaxel in women with breast cancer[J]. J Clin Oncol, 2005, 23(31): 7794-7803.
7Onetto N, Canetta R, Winograd B, et al. Overview of Taxol safety[J]. J Natl Cancer Inst Monogr, 1993, 5(15): 131-139.
8New PZ, Jackson CE, Rinaldi D, et al. Peripheral neuropa- thy secondary to docetaxel (Taxotere)[J]. Neurology, 1996, 46(1): 108-111.
9Scuteri A, Nicolini G, Miloso M, et al. Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells[J]. Antican- cer Research, 2006, 26(2A): 1065-1070.
4Walker M, Ni O. Neuroprotection during chemotherapy: a systematic review. Am J Clin One, 2007,30 : 82- 90.
5Hildebrand J. Neurological complications of cancer chemotherapy. Curr Opin Oncol,2006, 18 : 321 - 324.
6Ocean AJ , Vahdat LT. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Support Care Cancer,2004, 12 : 619 - 625.
7Grothey A, Nikevich JA, Sloan JA, et al. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol, 2011,29 : 421 - 427.
8Xiao WH, Bennett GJ. Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine. Pain, 2008, 135 : 262 N 270.
9Callizot N, Andriambeloson E, Glass J, et al. Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity. Cancer Chemother Pharmacol, 2008,62 : 995 - 1007.
10yon Delius S, Eckel F, Wagenpfeil S, et al. Car- bamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer : final results of a randomised, controlled, multicenter phase II study. Invest New Drugs, 2007,25 : 173 - 180.
